Clinicohematologic Observations of Acute Leukemias with Hyperleukocytosis.
- Author:
Young Hahk LEE
1
;
Dong Woo HYUN
;
Jung Gyun KIM
;
Sun Kun BAE
;
Dong Suk KWAK
;
Sang Kyun SOHN
;
Jae Tae LEE
;
Kyu Bo LEE
Author Information
1. Department of Internal Medicine, Kyungpook National University Hospital, Taegu, Korea.
- Publication Type:Original Article
- Keywords:
Acute Leukemias Hyperieukocytosis
- MeSH:
Anemia;
Central Nervous System;
Drug Therapy;
Female;
Hepatomegaly;
Humans;
Hyperuricemia;
Incidence;
Leukapheresis;
Leukemia*;
Leukocytes;
Leukostasis;
Male;
Mortality;
Myelodysplastic Syndromes;
Precursor Cell Lymphoblastic Leukemia-Lymphoma;
Prognosis;
Remission Induction;
Retrospective Studies;
Survival Rate
- From:Korean Journal of Medicine
1997;52(4):534-541
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVES: It is well known that Acute Leukemic patients with Hyperleukocytosis (ALH, leukocyte count>or=100,000/micro L) have poor prognosis. This is indebted in fatal complications arising from cerebral and pulmonary leukostasis. To investigate the factors influence on the prognosis of these patients, we have analyzed age, sex, laboratory findings and complications and their relationship to remission rate. METHODS: Retrospective evaluation was done from January 1985 to March 1994 on fifty-four patients with ALH. We excluded secondary leukemias transformed from chronic myelogeneous leukemia, relapsed acute leukemia and myelodysplastic syndrome in this study. The prognostic factors associated with early death were also evaluated. RESULTS: 1) Hyperuricemia and incidence of central nervous system and respiratory symptoms were higher in acute myelogeneous leukemia (AML) with hyperleu-kocytosis than in acute lymphocytic leukemia (ALL), 2) Twenty-two of fifty-four patients had complete remission by remission induction chemotherapy. Remission rate was 41%, median duration of remission was 26 weeks and 1 year survival rate was 11%. 3) There were no differences in remission rate between male and female and higher WBC group (WBC>or=200,000/micro L) and lower WBC group (WBC 100,000~200,000/micro L). 4) The group with better performance status (ECOG score1-2), younger (age below 40) and higher hemoglobin level (Hb>or=10g/dL) had higher remission rate. The group of AML and with hepatomegaly had lower remission rate than the group of ALL and without hepatomegly. 5) Early death rate of AML was higher than that of All. Infection was the most common cause of early death in both AML and ALL. 6) Early death rate between the two groups managed with and without leukapheresis was not different. CONCLUSIONS: This result reveals that acute leukemia with hyperleukocytosis is grave disease, especially the patients with poor performance status (ECOG score: 3-4), older age above 40 and severe anemia (Hb<10g/dL) have poor prognosis, The group of AML and with hepatomegaly showed worse prognosis than the group of ALL and without hepatomegaly.
